Arrhythmia Management in the Elderly-Implanted Cardioverter Defibrillators and Prevention of Sudden Death

Area of Science:

• Cardiology
• Geriatrics
• Medical Ethics

Background:

• Arrhythmia management in the elderly presents unique challenges due to patient frailty and complex goals of care.
• Implantable cardioverter defibrillators (ICDs) are a key therapy for preventing sudden cardiac death (SCD) in patients with ventricular arrhythmias.

Purpose of the Study:

• To provide an overview of implantable cardioverter defibrillator (ICD) therapy for arrhythmia management and sudden cardiac death prevention in elderly patients.
• To discuss the complexities, evidence, risk stratification, and ethical considerations of ICD use in this demographic.

Main Methods:

• Review of current practices in ICD therapy for elderly patients.
• Analysis of existing evidence from clinical trials and registries.
• Discussion of risk stratification approaches and ethical considerations.

Main Results:

• The incidence of sudden cardiac death as a percentage of all-cause mortality decreases with age.
• A significant proportion of elderly patients at risk for ventricular arrhythmias die from nonarrhythmic causes, termed the 'sudden cardiac death paradox'.
• Evidence from trials and registries highlights uncertainties regarding ICD appropriateness in the elderly.

Conclusions:

• ICD therapy is an option for selected elderly patients at risk of ventricular arrhythmia and sudden cardiac death.
• The decision for ICD insertion in the elderly requires careful consideration of evidence, patient frailty, and ethical factors.
• Further clinical and research strategies are needed to optimize ICD use in the growing elderly population.